BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29179987)

  • 1. Identification of genes involved in the four stages of colorectal cancer: Gene expression profiling.
    Shi G; Wang Y; Zhang C; Zhao Z; Sun X; Zhang S; Fan J; Zhou C; Zhang J; Zhang H; Liu J
    Mol Cell Probes; 2018 Feb; 37():39-47. PubMed ID: 29179987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key genes in colorectal cancer using random walk with restart.
    Cui X; Shen K; Xie Z; Liu T; Zhang H
    Mol Med Rep; 2017 Feb; 15(2):867-872. PubMed ID: 28000901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RRP9 and DDX21 as new biomarkers of colorectal cancer.
    Chi X; Yang N; Liu Y
    Medicine (Baltimore); 2023 Oct; 102(43):e34384. PubMed ID: 37904456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
    Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
    Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The key genes underlying pathophysiology association between the type 2-diabetic and colorectal cancer.
    Peng WF; Bai F; Shao K; Shen LS; Li HH; Huang S
    J Cell Physiol; 2018 Nov; 233(11):8551-8557. PubMed ID: 29319171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
    Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
    Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-protein interaction networks and modules analysis for colorectal cancer and serrated adenocarcinoma.
    Yu H; Ye L; Wang J; Jin L; Lv Y; Yu M
    J Cancer Res Ther; 2015; 11(4):846-51. PubMed ID: 26881529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer.
    Zhen YB; Guo XL; Xu B; Zhao HW; Xu CJ
    Neoplasma; 2016; 63(6):856-864. PubMed ID: 27565323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.
    Makondi PT; Chu CM; Wei PL; Chang YJ
    PLoS One; 2017; 12(7):e0180616. PubMed ID: 28749961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate Cancer.
    Dai L; Song ZX; Wei DP; Zhang JD; Liang JQ; Wang BB; Ma WT; Li LY; Dang YL; Zhao L; Zhang LM; Zhao YM
    Adv Ther; 2021 Jun; 38(6):2973-2989. PubMed ID: 33881746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.
    Yan H; Li Z; Shen Q; Wang Q; Tian J; Jiang Q; Gao L
    Pathol Res Pract; 2017 Apr; 213(4):316-321. PubMed ID: 28238542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression analysis of lung adenocarcinoma and matched adjacent non-tumor lung tissue.
    Zhang W; Gong W; Ai H; Tang J; Shen C
    Tumori; 2014; 100(3):338-45. PubMed ID: 25076248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Key Candidate Genes and Pathways in Colorectal Cancer by Integrated Bioinformatical Analysis.
    Guo Y; Bao Y; Ma M; Yang W
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
    Makondi PT; Lee CH; Huang CY; Chu CM; Chang YJ; Wei PL
    PLoS One; 2018; 13(1):e0189582. PubMed ID: 29342159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new hub genes associated with bladder carcinoma via bioinformatics analysis.
    Jia Z; Ai X; Sun F; Zang T; Guan Y; Gao F
    Tumori; 2015; 101(1):117-22. PubMed ID: 25702669
    [TBL] [Abstract][Full Text] [Related]  

  • 19.  CUL4B, NEDD4, and UGT1As involve in the TGF-β signalling in hepatocellular carcinoma.
    Qu Z; Li D; Xu H; Zhang R; Li B; Sun C; Dong W; Zhang Y
    Ann Hepatol; 2016; 15(4):568-76. PubMed ID: 27236156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mining and exploration of rehabilitation nursing targets for colorectal cancer.
    Li R; He J; Ni Z; Zhang J; Chi X; Kang C; Li Z; Li X
    Aging (Albany NY); 2024 Apr; 16(8):7022-7042. PubMed ID: 38637125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.